braf v600e antibody clone ve1 Search Results


90
Merck KGaA braf v600e (clone ve1) antibody
Braf V600e (Clone Ve1) Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/braf v600e (clone ve1) antibody/product/Merck KGaA
Average 90 stars, based on 1 article reviews
braf v600e (clone ve1) antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Eurobio anti-braf v600e mutant-specific antibody clone ve1
Comparison of BRAF and NRAS results by allele specific amplification, Sanger sequencing, IHC and Idylla testing.
Anti Braf V600e Mutant Specific Antibody Clone Ve1, supplied by Eurobio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-braf v600e mutant-specific antibody clone ve1/product/Eurobio
Average 90 stars, based on 1 article reviews
anti-braf v600e mutant-specific antibody clone ve1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Comparison of BRAF and NRAS results by allele specific amplification, Sanger sequencing, IHC and Idylla testing.

Journal: PLoS ONE

Article Title: Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay

doi: 10.1371/journal.pone.0221123

Figure Lengend Snippet: Comparison of BRAF and NRAS results by allele specific amplification, Sanger sequencing, IHC and Idylla testing.

Article Snippet: Slides were stained with anti-BRAF V600E mutant-specific antibody (clone VE1, dilution 1:200, pH9, Eurobio) [ ] .

Techniques: Comparison, Amplification, Sequencing, Mutagenesis

A. Control of samples found positive for BRAF mutation by ASA/Sequencing but negative by IHC. B. Control of samples found negative for BRAF mutation by ASA/sequencing and positive by IHC (wrong chromogen used). C. Control of samples found positive for NRAS mutation by sequencing but negative by Idylla. Yellow dots correspond to wild type DNA copies ( BRAF , panels A and B; NRAS , panel C). Green dots correspond to mutated DNA copies ( BRAF V600E, panels A and B; NRAS Q61R, panel C). Grey dots correspond to empty wells.

Journal: PLoS ONE

Article Title: Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay

doi: 10.1371/journal.pone.0221123

Figure Lengend Snippet: A. Control of samples found positive for BRAF mutation by ASA/Sequencing but negative by IHC. B. Control of samples found negative for BRAF mutation by ASA/sequencing and positive by IHC (wrong chromogen used). C. Control of samples found positive for NRAS mutation by sequencing but negative by Idylla. Yellow dots correspond to wild type DNA copies ( BRAF , panels A and B; NRAS , panel C). Green dots correspond to mutated DNA copies ( BRAF V600E, panels A and B; NRAS Q61R, panel C). Grey dots correspond to empty wells.

Article Snippet: Slides were stained with anti-BRAF V600E mutant-specific antibody (clone VE1, dilution 1:200, pH9, Eurobio) [ ] .

Techniques: Control, Mutagenesis, Sequencing

Discordant genotyping results.

Journal: PLoS ONE

Article Title: Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay

doi: 10.1371/journal.pone.0221123

Figure Lengend Snippet: Discordant genotyping results.

Article Snippet: Slides were stained with anti-BRAF V600E mutant-specific antibody (clone VE1, dilution 1:200, pH9, Eurobio) [ ] .

Techniques: Digital PCR